Point-of-care uric acid testing is useful in routine clinical care of gout

Correlation between Standard Clinical Chemistry and Point of Care Testing Analyzers on Hemoglobin A1C Determination

Point-of-care testing: is faster better?

Does the faster turnaround time for point-of-care testing (POCT) lead to better outcomes? Do the benefits justify the usually higher reagent costs and the expense and complexity of regulatory compliance? The answer, after 20 years of investigation, is an unequivocal " It depends. " It depends on the analyte and the testing device, on the reasons for testing, and on the setting of the testing, a...

Can We Apply the Control Material from Standard Clinical Chemistry Analyzer for Usage in the Point of Care Testing Analyzer?

Uric acid production in gout.

Point-of-care nucleic acid testing for infectious diseases.

Nucleic acid testing for infectious diseases at the point of care is beginning to enter clinical practice in developed and developing countries; especially for applications requiring fast turnaround times, and in settings where a centralized laboratory approach faces limitations. Current systems for clinical diagnostic applications are mainly PCR-based, can only be used in hospitals, and are st...